CD Biopharma Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

CD Biopharma General Information

Description

Developer of biopharmaceuticals focused on immune regulation mechanisms. The company's immune therapies for cancer and autoimmune diseases utilize a double-target fusion protein platform created through three core technologies, providing patients with cancer immune drugs.

Contact Information

Website
cdbiopharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 610, North Building
  • No. 689 Binhe Road, Huqiu District
  • Suzhou, Jiangsu
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Room 610, North Building
  • No. 689 Binhe Road, Huqiu District
  • Suzhou, Jiangsu
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CD Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 26-Jul-2024 Completed Generating Revenue
3. Early Stage VC 27-Sep-2023 Completed Generating Revenue
2. Early Stage VC 11-Jan-2023 Completed Generating Revenue
1. Early Stage VC 29-Jun-2022 Completed Generating Revenue
To view CD Biopharma’s complete valuation and funding history, request access »

CD Biopharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sanjie Investment Group Venture Capital Minority
Proxima Capital Venture Capital Minority
To view CD Biopharma’s complete investors history, request access »

Ready to get started?

Request a free trial

CD Biopharma FAQs

  • When was CD Biopharma founded?

    CD Biopharma was founded in 2021.

  • Where is CD Biopharma headquartered?

    CD Biopharma is headquartered in Suzhou, China.

  • What industry is CD Biopharma in?

    CD Biopharma’s primary industry is Drug Discovery.

  • Is CD Biopharma a private or public company?

    CD Biopharma is a Private company.

  • What is CD Biopharma’s current revenue?

    The current revenue for CD Biopharma is .

  • Who are CD Biopharma’s investors?

    Sanjie Investment Group and Proxima Capital have invested in CD Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process